1. Home
  2. OVID vs BSAA Comparison

OVID vs BSAA Comparison

Compare OVID & BSAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • BSAA
  • Stock Information
  • Founded
  • OVID 2014
  • BSAA 2025
  • Country
  • OVID United States
  • BSAA Hong Kong
  • Employees
  • OVID N/A
  • BSAA N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • BSAA Blank Checks
  • Sector
  • OVID Health Care
  • BSAA Finance
  • Exchange
  • OVID Nasdaq
  • BSAA Nasdaq
  • Market Cap
  • OVID 88.9M
  • BSAA 74.4M
  • IPO Year
  • OVID 2017
  • BSAA 2025
  • Fundamental
  • Price
  • OVID $1.72
  • BSAA $10.06
  • Analyst Decision
  • OVID Strong Buy
  • BSAA
  • Analyst Count
  • OVID 4
  • BSAA 0
  • Target Price
  • OVID $3.13
  • BSAA N/A
  • AVG Volume (30 Days)
  • OVID 5.1M
  • BSAA 9.4K
  • Earning Date
  • OVID 11-11-2025
  • BSAA 01-01-0001
  • Dividend Yield
  • OVID N/A
  • BSAA N/A
  • EPS Growth
  • OVID N/A
  • BSAA N/A
  • EPS
  • OVID N/A
  • BSAA N/A
  • Revenue
  • OVID $6,651,000.00
  • BSAA N/A
  • Revenue This Year
  • OVID $1,086.57
  • BSAA N/A
  • Revenue Next Year
  • OVID N/A
  • BSAA N/A
  • P/E Ratio
  • OVID N/A
  • BSAA N/A
  • Revenue Growth
  • OVID 1070.95
  • BSAA N/A
  • 52 Week Low
  • OVID $0.24
  • BSAA $9.82
  • 52 Week High
  • OVID $2.01
  • BSAA $10.32
  • Technical
  • Relative Strength Index (RSI)
  • OVID 63.50
  • BSAA N/A
  • Support Level
  • OVID $1.24
  • BSAA N/A
  • Resistance Level
  • OVID $2.01
  • BSAA N/A
  • Average True Range (ATR)
  • OVID 0.20
  • BSAA 0.00
  • MACD
  • OVID 0.03
  • BSAA 0.00
  • Stochastic Oscillator
  • OVID 66.29
  • BSAA 0.00

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

About BSAA BEST SPAC I Acquisition Corp. Class A Ordinary Shares

BEST SPAC I Acquisition Corp is a blank check company.

Share on Social Networks: